Top Section/Ad
Top Section/Ad
Most recent
Cell and gene therapy company plans US expansion
String of exits mean reliable source of deal flow is at risk
More articles/Ad
More articles/Ad
More articles
-
Second European IPO announced in Czech Republic
-
Smaller deals open markets in France and Austria
-
JP Morgan will take early lead in league table
-
Doubts linger over IPO market but some hope 2025 will be the year of sell-downs
-
Early ECM activity concentrated in Italy and Nordics
-
Apollo to sell €316m of Lottomatica on Wednesday night